Repeated dexamethasone suppression test in depressed patients.

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• The dexamethasone suppression test (DST) is a biological marker used in diagnosing depression.
• Abnormal DST results are common in patients with major depressive disorder.

Purpose of the Study:

• To investigate the relationship between DST normalization and clinical improvement in depressed patients undergoing antidepressant therapy.
• To determine if DST normalization predicts the timing of symptomatic improvement and recovery.

Main Methods:

• 17 depressed patients with initially abnormal DST results were monitored.
• Serial plasma cortisol levels were measured after dexamethasone administration.
• Clinical severity ratings were assessed throughout treatment.

Main Results:

• DST normalized gradually during selective antidepressant therapy, correlating with clinical mood improvement.
• DST normalization preceded symptomatic improvement by approximately 24.5 days.
• DST normalization predicted the time to clinical improvement but not full recovery.
• The DST differentiated between severe and less severe depression.

Conclusions:

• DST normalization is an early biological marker during antidepressant treatment for depression.
• The DST can serve as a predictor for clinical improvement in depression.
• Age influences the duration of severe depression, with elderly patients experiencing longer episodes.